Wed, March 27, 2024
Tue, March 26, 2024
Mon, March 25, 2024
Fri, March 22, 2024

Mathew Blackman Upgraded (TNDM) to Strong Buy and Increased Target to $37 on, Mar 26th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-37-on-mar-26th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Mathew Blackman of Stifel, Upgraded "Tandem Diabetes Care, Inc." (TNDM) to Strong Buy and Increased Target from $24 to $37 on, Mar 26th, 2024.

Mathew has made no other calls on TNDM in the last 4 months.



There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, all agree with Mathew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $31 on, Friday, March 15th, 2024
  • Rick Wise of "Stifel" Maintained at Hold with Increased Target to $24 on, Monday, February 5th, 2024

Publication Contributing Sources